Pharmaceutical cannabis: American interest in export investments in Greece

The intense interest of representatives of important American companies for investments in the field of medical cannabis in Greece, was recorded in an online event co-organized on Thursday, May 20, by the Hellenic Investment and Foreign Trade Company SA. (Enterprise Greece), the well-known American law firm Duane Morris and the Office of Economic and Commercial Affairs of the Consulate General of Greece in New York.

Seeing investment opportunities in the pharmaceutical cannabis sector in our country, Duane Morris, addressed companies that are exploring new investment opportunities and the majority of them attended the event, with the participation exceeding the initial forecasts, and reaching 120 participants.

As pointed out during the webinar, the new bill promoted by the Greek government paves the way for the production of processed cannabis products of all forms, including dried buds in 30 gram packages exclusively for export, regardless of whether they are intended to be used as a final or intermediate product or as a raw material for medical and pharmaceutical purpose sin the importing country .

With this important legislative intervention, as it was pointed out, the constant needs of the market are met, but also the demand for dried buds, mainly from Europe. This regulation is accompanied by simplification of approval procedures, improvement of location issues, ensuring the safe and unhindered disposal of medicinal cannabis products, under the control of the National Pharmaceutical Organization, to meet the prescribed needs of patients with serious underlying diseases. Its main goal is to unblock approved investments that remain stagnant in the country and pave the way for attracting young people from mature markets such as the US.